Healthcare Stock Ideas

Healthcare Stock Ideas

New Idea: Strata Critical Medical (NASDAQ: SRTA)

A transplant roll-up at about 10x EBITDA, and an activist who just found the same number.

Healthcare Stock Ideas's avatar
Healthcare Stock Ideas
Oct 16, 2026
∙ Paid

This is a business with:

  • Revenue up 60.7% year-over-year in the most recent quarter, with full-year guidance raised from $260-275 million to $285-295 million

  • Adjusted EBITDA guidance lifted to $33-35 million, against $14.1 million for the whole of last year

  • Three bolt-on acquisitions closed in a single quarter at mid-single-digit EBITDA multiples, while the company itself is valued at roughly 10x guided EBITDA

  • Under 10% share of its largest service market and around 5% of another, in an industry growing mid to high single digits before any share gains

  • The only end-to-end operator in its niche, by its own count against nine competitors

  • A structural volume driver that has gone from 4.4% adoption in 2022 to 58.7% today, with management modelling the low 60s by 2028

  • Two consecutive quarters of positive free cash flow before aircraft purchases after years of burn, and a $17.5 million earn-out expected before year-end

  • Roughly $200 million of capital management says it can deploy through 2029, into a market of local operators who cannot compete nationally

  • A 5.8% activist stake disclosed this week, with a call for a review of strategic alternatives

The setup is almost boringly predictable: buy small regional operators at mid-single-digit multiples, plug them into a national platform, watch fixed costs get spread over a bigger base.

Except there is a catch, and it is a real one. The adjusted EBITDA figure everyone quotes adds back stock-based compensation that runs at roughly half of adjusted EBITDA. Strip that out and the multiple doubles.

In my view that single line is the whole debate on this stock.

As of this week, an activist thinks so too.

Here’s everything you need to know...

This post is for paid subscribers

Already a paid subscriber? Sign in
© 2026 Healthcare Stock Ideas · Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for great culture